肝移植受者全关节置换术后发病率与死亡率无差异:基于全民医保数据的全国性人群倾向评分匹配分析
该全国性人群研究利用全民医保数据库分析2001年1月至2014年12月接受全关节置换术的患者,共纳入43例肝移植受者和350337例非肝移植患者。倾向评分匹配后,肝移植受者30天并发症、30天再入院、90天并发症、1年感染、再手术率及死亡率的调整比值比均无显著差异。作者认为肝移植受者全关节置换术后的发病率与死亡率似乎与非肝移植患者相当。
要点
- 肝移植后接受全关节置换术的患病率为1.3%(43/3276)。
- 匹配后肝移植受者30天并发症aOR 0.98(95%CI 0.93-1.03;P=.35),无显著差异。
- 匹配后死亡率aOR 0.91(95%CI 0.80-1.04;P=.18),无显著差异。
核心结论
- 肝移植受者与非肝移植患者全关节置换术后的发病率与死亡率似乎相当。
- 作者认为风险评估方法在肝移植受者中是可行的。
研究设计与样本
- 全国性人群研究,数据提取自全民健康保险数据库,基于国际疾病分类第九版临床修订版。
- 纳入2001年1月至2014年12月期间接受全关节置换术的患者,排除双侧全关节置换或肝移植前接受全关节置换者。
- 共纳入43例肝移植患者和350337例非肝移植患者,采用1比10倾向评分匹配,并使用多变量逻辑回归控制混杂变量。
主要发现
- 肝移植后接受全关节置换术的患病率为1.3%(43/3276)。
- 倾向评分匹配后,肝移植与30天并发症无关联(aOR 0.98;95%CI 0.93-1.03;P=.35)。
- 倾向评分匹配后,肝移植与30天再入院率无关联(aOR 0.93;95%CI 0.92-1.08;P=.87)。
- 倾向评分匹配后,肝移植与90天并发症率无关联(aOR 0.95;95%CI 0.88-1.02;P=.16)。
- 倾向评分匹配后,肝移植与1年感染率(aOR 1.04;95%CI 0.96-1.12;P=.35)、再手术率(aOR 1.06;95%CI 0.92-1.23;P=.41)及死亡率(aOR 0.91;95%CI 0.80-1.04;P=.18)均无关联。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Controversy remains regarding the outcomes after total joint arthroplasty (TJA) among patients with or without liver transplantation (LT). This study aimed at investigating the prevalence of TJA in patients after LT and comparing the morbidity and mortality with the non-LT group. METHODS: We conducted a nationwide, population-based study, with data extracted from a universal health insurance database, based on the International Classification of Disease, Ninth Revision, Clinical Modification. Patients who underwent TJAs between January 2001 and December 2014 were included. Patients who had bilateral TJAs or a TJA before LT were excluded. A total of 43 patients with LT and 350,337 patients without LT were included. The analysis was implemented using data from all patients and those matched by 1-to-10 propensity score matching. Multivariable logistic regression was used to control confounding variables. RESULTS: The prevalence of patients undergoing TJA after LT was 1.3% (43/3276). After propensity score matching, patients with LT were not associated with 30-day complications (adjusted odds ratio [aOR], 0.98; 95% confidence interval [CI], 0.93-1.03; P = .35), 30-day readmission rates (aOR, 0.93; 95% CI, 0.92-1.08; P = .87), 90-day complication rates (aOR, 0.95; 95% CI, 0.88-1.02; P = .16), 1-year infection rates (aOR, 1.04; 95% CI, 0.96-1.12; P = .35), reoperation rates (aOR, 1.06; 95% CI, 0.92-1.23; P = .41), or mortality (aOR, 0.91; 95% CI, 0.80-1.04; P = .18). CONCLUSION: The morbidity and mortality seem to be comparable whether TJA is performed in patients with or without LT. Methods for risk assessment would be feasible in liver transplant recipients.
引用
- Kuo FC, Chang CJ, Bell KL, et al. No Difference in Morbidity and Mortality After Total Joint Arthroplasty in Liver Transplant Recipients: A Propensity Score-Matched Analysis of a Nationwide, Population-Based Study Using Universal Healthcare Data. J Arthroplasty. 2018. PMID: 29941381. doi:10.1016/j.arth.2018.05.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。